RxDoctor Payments Data

Ching Yen Chang, MD

Otology & Neurotology · Bellaire, TXNPI 1316981392

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Optinose US, Inc. at 30.7% of the total. Reporting peaked in 2024 at $548 and has fallen 93.4% since, to $36 in 2025. That places this record below the midpoint for otology & neurotology clinicians in TX, where the typical reported total is $1,716.

$1,569in general payments, 2019–2025

Across 23 payments — averaging $68.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$482
  • Advanced Bionics, LLC$249
  • Cochlear Americas$224
  • Aerin Medical Inc.$145
  • Intersect ENT, Inc.$118
  • Sanofi$92
  • plus $258 from 6 others

What the payments were for

  • Food & beverage$1,569100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,569 in reported general payments places this provider in the 45th percentile of 33 otology & neurotology providers in Texas.

See all otology & neurotology providers in Texas

Medicare billing

Part B allowed, 2024
$130,584
Medicare patients
286
Services billed
821

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth104$17,573
Ofloxacin150$5,008
Dexamethasone Sodium Phosphate49$3,784
Zonisamide132$2,471
Amitriptyline Hcl22$1,011
Acetazolamide11$1,007
Nortriptyline Hcl27$440
Clotrimazole24$325
Cyclobenzaprine Hcl56$280
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid22$170
Fluticasone Propionate14$162
Tramadol Hcl53$152
Promethazine Hcl23$118
Lorazepam18$78

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Bellaire

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →